McKesson Corporation (MCK) Financial Statements
Historical financial data — 45 statements covering FY2016–FY2026
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, inde...
McKesson Corporation's revenue increased 12.4% year over year, from $359.05B to $403.43B.
Net income increased 44.5% over the same period, from $3.29B to $4.76B.
Over the 10-year period from FY2016 to FY2026, revenue grew by 111% in total.
Total debt increased by 55.1% to $8.79B.
Operating cash flow grew 1.2% to $6.16B.
McKesson Corporation maintains a moderate net profit margin of 1.2%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2025 | $93.65B+18.1% | $241.0M | $3.16B | $574.0M | $2.10B | $72.43B | $7.25B | $-2.64B |
| Q3 FY2025 | $95.29B+1.8% | $879.0M | $3.37B | $1.23B | $-2.38B | $71.08B | $6.85B | $-3.08B |
| Q4 FY2025 | $90.82B-4.7% | $1.26B | $3.64B | $1.59B | $7.75B | $75.14B | $5.66B | $-2.07B |
| Q1 FY2026 | $97.83B+7.7% | $784.0M | $3.28B | $1.04B | $-918.0M | $81.31B | $7.73B | $-1.97B |
| Q2 FY2026 | $103.15B+5.4% | $1.11B | $3.54B | $1.41B | $2.42B | $84.16B | $7.71B | $-1.74B |
| Q3 FY2026 | $106.16B+2.9% | $1.19B | $3.69B | $1.62B | $1.23B | $84.19B | $6.53B | $-1.30B |
| Q4 FY2026 | $96.30B-9.3% | $1.68B | $4.04B | $2.15B | $3.42B | $82.32B | $8.79B | $-834.0M |
| Q1 FY2027 | $105.38B+9.4% | $614.0M | $3.69B | $1.32B | $-220.0M | $88.33B | $11.80B | $-1.30B |
Balance Sheet Summary (Q1 FY2027)
McKesson Corporation (MCK) Financial Statements & Revenue History
McKesson Corporation (MCK) is a US-listed stock operating in the Healthcare sector, specifically the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry trading at $1004.84 with a market capitalization of $117. This page provides 45 historical financial statements for McKesson Corporation, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, McKesson Corporation reported revenue of $403.4 billion, representing 12.4% year-over-year growth. The net profit margin of 1.2% suggests thin margins..
MCK Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows McKesson Corporation's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether MCK is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track MCK's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently McKesson Corporation converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of MCK's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use MCK Financial Data
Investors use McKesson Corporation's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare MCK's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how MCK's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View MCK's financial health score, earnings, and pre-market pricing.
Financial data is sourced from McKesson Corporation's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.MCK trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.